CANCER SYMPTOM CONTROL

癌症症状控制计划由17个参与成员组成，代表了每年直接成本414万美元（总成本565万美元）的同行评审资金总额。在过去两年中，其成员共发表了100篇与癌症相关的同行评议出版物，其中29%是规划内和规划间的合作。这个项目以前被称为“姑息治疗”，致力于研究癌症对人类意识和感官体验的影响。它由成员组成，他们对癌症的后果及其治疗对患者生活质量的影响进行了高度连锁的研究。这些检查由癌症引起的疼痛、疲劳、焦虑、抑郁和睡眠破碎，以及如何最好地改善这些症状，以提高生活质量和对医疗保健的满意度。这些研究还检查了医生和病人之间沟通的效率，以及病人的种族和文化特征对疾病主观体验的影响。该项目在减轻与癌症相关的身体和精神痛苦方面进行了基础和临床研究。当然，癌症患者本身是这项症状控制研究的主要受益者，但他们的家人患有严重疾病。该项目成员在以下方面开发了一系列针对癌症患者的高度特异性研究：(1)癌症疼痛综合征；(2)癌症患者的疲劳和睡眠；(3)癌症患者的生活质量。

The Cancer Symptom Control Program consists of 17 Participating Members, representing total peer-reviewed funding for $4.14 Million annual direct costs ($5.65 Million in total costs). During the last two years, its members were responsible for a total of 100 cancer-relevant, peer-reviewed publications, 29% of which were intra- and inter- programmatic collaborations. This Program, formerly called "Palliative Care", is dedicated to research on the impact of cancer on human consciousness and sensory experience. It is comprised of members who are conduct highly interlocking studies on the consequences of cancer and its treatment on the quality of life of the patient. These examine pain, fatigue, anxiety, depression and sleep fragmentation, caused by cancer and how these can best be ameliorated to improve quality of life and satisfaction with medical care. The studies also examine the efficience of communications between doctors and their patients and the effect of ethnic and cultural characteristics of the patients of the subjective experience of the disease. This Program brings to bear both basic and clinical research on mitigating the physical and mental anguish associated with cancer. Of course, the cancer patients themselves are the main beneficiaries of this research on symptom control, but their families with severe illnesses. Members of this Program have developed a series of studiers highly specific to cancer patients in terms of: (1) cancer pain syndromes; (2) fatigue and sleep in cancer patients, and; (3) quality of life in cancer patients.